VUNO Brags about AI Solutions and Research Results at RSNA 2021
VUNO will present four medical artificial intelligences solutions: VUNO MedÂ®-Thoracic Radius â¢, VUNO MedÂ®âLungCT AI â¢, VUNO MedÂ®-DeepBrainÂ® and VUNO MeanÂ®-Bone ageâ¢ which can be seamlessly integrated with PACS (Picture Archiving and Communication System), EMR (Electronic Medical Record) or any other medical device. A virtual reading room connected to the PACS system will be installed in the VUNO stand so that visitors can have an overview of VUNO MedÂ® solutions integrated into PACS.
VUNO will present the future R&D direction of VUNO at the AI ââTheater under the theme âThe past, present and future of VUNO Med for precision imagingâ. Then, nine research achievements will be presented during a research presentation session. It includes topics encompassing various areas of medical imaging, such as MRI-based AI model in predicting MCI to dementia, AI-assisted diagnosis to diagnose lung nodule malignancy, Basal lung metastases in patients with colon cancer.
In addition, VUNO will participate in IAIP (Imaging AI in Practice), a virtual demonstration program developed to effectively demonstrate the effects of AI solutions in clinical settings. The company will present VUNO MedÂ®âLungCT AI â¢ on this program to demonstrate how it works using real-world clinical scenarios.
Hyun Jun Kim, CEO of VUNO said, âThrough participation in RSNA 2021, we will showcase various clinical research achievements to global leaders in radiology using AI technology,â said Hyun-jun Kim, CEO of VUNO, adding âWe plan to expand our partnerships with partner companies abroad. and medical institutions by offering participants the opportunity to experience VUNO Med first-handÂ® solutions. “
SOURCE VUNO inc.